explaining vta neurons hyperactive mice destined stress induced depression not resistant animals caveat comes david nutt imperial college london points like new resilience drug candidates standard depression treatments like prozac diminish hyperactivity neurons different set cells think resilience current antidepressant drugs work nutt says neuropsychopharmacologist suggests novel approach involve psychedelic drugs psilocybin potential antidepressant effects ezogabine represents means potentially enhance resilience researchers mount sinai considering ways regulating reward system modulating gene activity brain signaling molecules neurotransmitters unlike clinical trials emphasize relief symptoms primary objective ezogabine study goal gage therapy addresses biological underpinnings depression case drug lessens hyperactivity reward circuit includes